UTMD · Insider Trading
Utah Medical Products Inc
Every open-market purchase and sale reported by UTMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Paul O Richins | Director | G | −150 | −$10.96K |
| 2026-05-29 | Brian Koopman | Principal Financial Officer | G | −50 | −$3.31K |
| 2025-11-25 | Brian Koopman | Principal Financial Officer | A | +500 deriv. | — |
| 2025-09-05 | Brian Koopman | Principal Financial Officer | G | −50 | −$3.14K |
| 2025-08-26 | Paul O Richins | Director | G | −100 | −$6.03K |
| 2024-11-08 | Brian Koopman | Principal Financial Officer | A | +500 deriv. | — |
| 2024-07-22 | Brian Koopman | Principal Financial Officer | G | −50 | −$3.58K |
| 2024-05-17 | Paul O Richins | Director | G | −225 | −$15.69K |
| 2023-12-26 | Brian Koopman | Principal Financial Officer | A | +500 deriv. | — |
| 2023-06-20 | Brian Koopman | Principal Financial Officer | G | −60 | −$5.66K |
| 2023-05-19 | Paul O Richins | Director | Sell | −700 | −$65.43K |
| 2023-03-17 | Paul O Richins | Director | G | −150 | −$13.88K |
| 2023-02-09 | Barbara A Payne | Director | G | −500 | −$45.00K |
| 2022-12-06 | Brian Koopman | Principal Financial Officer | MIXED | +134 | +$32 |
| 2022-11-21 | Paul O Richins | Director | Sell | −449 | −$40.77K |
| 2022-11-17 | Paul O Richins | Director | Sell | −161 | −$14.49K |
| 2022-11-15 | Paul O Richins | Director | Sell | −40 | −$3.70K |
| 2022-11-03 | Brian Koopman | Principal Financial Officer | G | −65 | −$5.78K |
| 2022-10-25 | Brian Koopman | Principal Financial Officer | A | +1,000 deriv. | — |
| 2022-06-27 | Paul O Richins | Director | G | −250 | −$22.25K |
| 2022-05-11 | Barbara A Payne | Director | Sell | −2,000 | −$170.40K |
| 2022-02-10 | Barbara A Payne | Director | G | −500 | −$49.47K |
| 2021-12-13 | Paul O Richins | Director | M | +62 | +$3.14K |
| 2021-11-26 | Ernst G Hoyer | Director | Sell | −5,000 | −$631.93K |
| 2021-11-23 | Kevin L Cornwell | Chairman, CEO, Secretary | G | −2,000 | −$249.50K |
| 2021-11-18 | Barbara A Payne | Director | Sell | −2,000 | −$222.12K |
| 2021-10-28 | Brian Koopman | Principal Financial Officer | MIXED | +316 | +$103 |
| 2021-10-28 | Brian Koopman | Principal Financial Officer | A | +3,600 deriv. | — |
| 2021-08-30 | Barbara A Payne | Director | Sell | −1,999 | −$176.39K |
| 2021-08-27 | Barbara A Payne | Director | Sell | −1 | −$88 |
| 2021-03-12 | Paul O Richins | Director | G | −225 | −$20.81K |
| 2021-03-10 | Barbara A Payne | Director | Sell | −1,000 | −$90.00K |
| 2021-02-09 | Barbara A Payne | Director | G | −500 | −$45.49K |
| 2020-06-09 | Kevin L Cornwell | Chairman, CEO, Secretary | Sell | −1,000 | −$107.56K |
| 2020-06-05 | Barbara A Payne | Director | Sell | −1,000 | −$108.00K |
| 2020-06-05 | Kevin L Cornwell | Chairman, CEO, Secretary | Sell | −6,385 | −$679.02K |
| 2020-06-04 | Barbara A Payne | Director | Sell | −1,000 | −$102.04K |
| 2020-05-28 | Barbara A Payne | Director | Sell | −1,000 | −$95.00K |
| 2020-05-28 | Paul O Richins | Director | Sell | −650 | −$62.21K |
| 2020-05-27 | Barbara A Payne | Director | Sell | −770 | −$70.84K |
| 2020-05-22 | Barbara A Payne | Director | Sell | −230 | −$21.24K |
| 2020-05-19 | Barbara A Payne | Director | Sell | −1,000 | −$87.00K |
| 2020-05-13 | Paul O Richins | Director | G | −30 | −$2.47K |
| 2020-05-11 | Paul O Richins | Director | G | −200 | −$16.05K |
| 2020-02-21 | Barbara A Payne | Director | G | −500 | −$48.00K |
| 2019-12-13 | Kevin L Cornwell | Chairman, CEO, Secretary | Sell | −2,668 | −$285.51K |
| 2019-11-29 | Kevin L Cornwell | Chairman, CEO, Secretary | Sell | −800 | −$86.14K |
| 2019-11-19 | Barbara A Payne | Director | Sell | −694 | −$70.96K |
| 2019-11-13 | Barbara A Payne | Director | Sell | −6 | −$624 |
| 2019-11-12 | Barbara A Payne | Director | G | −300 | −$30.35K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Paul O Richins | Director | 43,144 | $3.22M |
| Brian Koopman | Principal Financial Officer | 782 | $58.29K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UTMD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.